Generic congressional ballot on Oct 26, 2026?
8.4%median
8.05%8.75%
Median 8.4%Middle half 8.18% – 8.63%
Install
Generic congressional ballot on Oct 20, 2026?
Settled 8%A day before, traders had a median of 8.27%
The last odds before it closed
8%median
- ✓ 8.0%88%▲ 64
- 8.1%5%▼ 2
- 7.9%2%▼ 24
- 7.8%2%▼ 5
- 8.2%1%▼ 1
- 8.4%1%▼ 1
- Below 7.8%<1%▼ 2
- 8.3%<1%▼ 1
- Above 8.4%<1%▼ 2
How the odds have moved
Median: 8.27% on Oct 19, 8% now.
The median the market implied over time and its middle half (the band), read from every strike's prices on Kalshi.
Every outcome
| Outcome | Last odds | Day | Bid | Ask | Pays | Contracts |
|---|---|---|---|---|---|---|
| ✗ Below 7.8% | <1% | 1.7K | ||||
| ✗ 7.8% | 2% | 590 | ||||
| ✗ 7.9% | 2% | 1.9K | ||||
| ✓ 8.0% | 88% | 3.2K | ||||
| ✗ 8.1% | 5% | 1.6K | ||||
| ✗ 8.2% | 1% | 1.1K | ||||
| ✗ 8.3% | <1% | 1.1K | ||||
| ✗ 8.4% | 1% | 2.0K | ||||
| ✗ Above 8.4% | <1% | 2.5K |
"Pays" is what a $1 stake returns if that outcome happens, at the price shown (before any fees). Bid and ask are the best prices to sell and buy "Yes".
The news: Generic
Search ›-
Can BMY Navigate Generic Challenges Across Its Key Drug Portfolio?Legacy portfolio revenues fell 5% year over year to $10.7 billion in the first half of 2026, primarily due to generic-related declines in Revlimid, Pomalyst, Sprycel and Abraxane. BMY also expects the price reduction implemented at the… -
Generic, cheaper Viagra is coming soon to an over-the-counter near youViagra improved the lives of millions of men -- now, it's becoming cheaper and more easily available. As drug giant Pfizer loses its patent monopoly over the most famous erectile dysfunction drug, Viagra is set to become a generic product… -
Zydus’ generic of hormone therapy patch gets U.S. FDA nodPublished - October 21, 2026 05:58 pm IST - HYDERABAD Zydus Lifesciences has received final approval from the U.S. Food and Drug Administration (FDA) for its abbreviated new drug application for Estradiol and Levonorgestrel Transdermal… - Wednesday’s Campaign Round-Up, 10.21.26: Democrats’ lead grows on the generic ballotMS NOW Todayâs installment of campaign-related news items from across the country For example, the survey found Democrats with an 11-poing advantage over Republicans on the generic congressional ballot, 52% to 41% The same poll showed…
- Generic Engineering Construction 52 Week Low Streak AnalysisGeneric Engineering Construction And Projects Ltd. has now traded within 2% of its 52-week low for its second straight session, with the stock down 19.47% across the streak. At 11:52 AM IST, the share price was at Rs 27.47 after touching a…
-
Kerala's free SMA scheme faces questions over generic drug's 'clinical trial' labelKerala’s free treatment programme for children with spinal muscular atrophy (SMA) has come under scrutiny after a government hospital reportedly distributed medicine carrying a label stating “for clinical trial”. The controversy has also… -
Why recognising a generic drug for Spinal Muscular Atrophy is significantThe Department of Health's adoption of affordable generic Risdiplam for Spinal Muscular Atrophy marks a major victory for patient access and public health The Department of Health decided to use a low-cost generic version of the SMA drug… -
A Builder-Grade Bathroom Felt "Generic" Until an Elevated and Calming RedoSKILL LEVEL: DIY, Professional "When we first bought the house, the bathroom had standard builder finishes and felt fairly generic," Lita Lee, founder of Stories from a Stylist, says. As an editorial interior stylist, Lita typically works… -
FDA approves first generic estradiol/levonorgestrel weekly patchThe FDA approved the first generic of Climara Pro, a weekly estradiol/levonorgestrel patch for VMS and osteoporosis prevention in women with a uterus. "Menopause is a universal experience for women, and it can greatly affect a person's… -
Generic of Combination Hormone Therapy Patch Approved for Women— Weekly estradiol-levonorgestrel system indicated for those with an intact uterus The FDA on Monday approved the first generic of the once-weekly estradiol and levonorgestrel transdermal system (Climara Pro) to treat moderate to severe… - Russian drugmaker Promomed registers localized generic of TrikaftaThe Pharma Letter
-
ACTF blasts use of AI-generated pitches as ‘generic, warped’ decks flood inAn AI-generated image similar to those used in pitches received by the ACTF The Australian Children’s Television Foundation (ACTF) has railed against the use of generative AI to develop new kids’ shows after an influx of low-quality…
Related markets
All politics ›María Corina Machado enters Venezuela by...?
>99%October 31
- October 31>99%▲ 89
- December 31>99%▲ 67
Blue wave in 2026?
82%chance▼ 2
Will Trump acquire Greenland before 2027?
2%chance▼ 1
Trump out as President before 2027?
5%chance▲ 1
Clarity Act (H.R.3633) signed into law in 2026?
3%chance▼ 1
Odds are traders' prices on Kalshi, Polymarket, ForecastEx and Crypto.com, not forecasts by 4Conservative. Prices read from the venues 5 min ago. Prices may be delayed. Money traded on Kalshi and ForecastEx is estimated from contracts. Not betting or investment advice.
Prediction-market prices are what traders pay for each outcome on Kalshi, Polymarket, ForecastEx and Crypto.com, read as the market's implied chance. They are not forecasts by 4Conservative, can move fast and can be wrong; they are read every few minutes and may be delayed. Money traded on Kalshi and ForecastEx is estimated from contracts at their price. News comes from the 4Conservative index; prices of stocks, rates and coins from 4Conservative Finance. Nothing here is betting, financial or investment advice. Terms of use. How to use Predictions